Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Texas Takes Aim at Telemedicine Care for Patients

By Drug Discovery Trends Editor | May 4, 2015

The state of Texas and telemedicine advocates are in a legal tussle over patients who receive doctor consultations through video.
 
The state’s medical board has implemented rules scheduled to take effect in June that place restrictions on the practice, drawing a rebuke from those who say the technology serves a crucial role, particularly in remote regions where doctors are few. A Dallas company, Teladoc, has filed a lawsuit to block the state’s action, arguing that it “would raise prices and reduce access to physician services in Texas.”
 
The lawsuit was filed Wednesday in federal court in Austin, against the backdrop of the growing use of telemedicine in physician care.
 
“It is clear that the medical board acted only when Teladoc consultations became sufficiently numerous to be perceived as a competitive threat to brick-and-mortar physician practices,” Teladoc CEO Jason Gorevic said in a statement announcing the lawsuit.
 
He argues that “not one shred of data was presented” during the Texas Medical Board’s discussions to support any claim that telemedicine can pose a risk to patients. The board also ignored comments by consumers, physicians and others opposing the regulations adopted April 10, said Gorevic, whose company is one of the leading telemedicine providers in the U.S.
 
The rules cover a few areas. One requirement is that patients travel to an “established medical site” for an initial appointment, although that meeting with a doctor may be either in-person or via teleconference. The patient could have the appointment from home as long as a medical assistant is present to relay vital signs and other data to the doctor.
 
Dr. Michael Arambula, president of the board, has said the intention is to ensure safe, quality care. He said in an earlier statement that the board wants to avoid any sort of initial treatment done by telephone that doesn’t provide “any objective diagnostic data” to help a doctor serve a patient.
 
“The board recognizes that as technology evolves, so too must regulations governing telemedicine,” Arambula said.
 
Gorevic noted that the rules require that a physician have an established relationship with a patient to provide treatment. “Imagine if you could only shop online from a store that you’d already visited in-person and how that would impact business innovation and customer care,” he said.
 
Jonathan Linkous, CEO of the American Telemedicine Association, said doctor-patient teleconferences are only a portion of a growing industry. He said telemedicine fills an important gap in rural areas that have a shortage of not just doctors who offer specialized care but also general practitioners.
 
Texas ranks 47th in the nation in primary care physicians per 100,000 people, according to AMN Healthcare. Thirty-five Texas counties have no physician; an additional 80 have five or fewer.
 
“The fact that medical boards are starting to pay attention to this is probably a good thing because that means telemedicine is playing a larger role in patient care,” Linkous said.

Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE